Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
51
# OF OVERLAPPING
HOLDINGS
XBI
116
HOLDINGS
45%
ALSO IN SBIO
SBIO
94
HOLDINGS
60%
ALSO IN XBI
SECTOR DRIFT (XBI minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
VIKING THERAPEUTICS, INC. | 1.5% | 2.6% | 1.5% |
|
AVIDITY BIOSCIENCES INC | 1.5% | 3.5% | 1.5% |
|
CYTOKINETICS INC | 1.5% | 2.5% | 1.5% |
|
VAXCYTE, INC. | 1.3% | 2.4% | 1.3% |
|
KRYSTAL BIOTECH, INC. | 1.2% | 2.5% | 1.2% |
XBI Overweight Relative to SBIO
|
ALNYLAM PHARMACEUTICALS INC | 3.6% |
|
HALOZYME THERAPEUTICS INC | 2.9% |
|
INCYTE CORP | 2.8% |
|
INSMED INC | 2.7% |
|
GILEAD SCIENCES INC | 2.7% |
|
UNITED THERAPEUTICS CORP | 2.7% |
|
REGENERON PHARMACEUTICALS | 2.7% |
|
ABBVIE INC | 2.5% |
|
NEUROCRINE BIOSCIENCES INC | 2.5% |
|
BIOMARIN PHARMACEUTICAL INC | 2.5% |
XBI Underweight Relative to SBIO
|
AXSOME THERAPEUTICS, INC. | -3.2% |
 |
MERUS N.V. | -3.0% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.4% |
|
RHYTHM PHARMACEUTICALS, INC. | -2.4% |
|
NUVALENT, INC. CLASS A | -2.1% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.1% |
|
AVIDITY BIOSCIENCES INC | -2.0% |
|
ACADIA PHARMACEUTICALS INC | -1.8% |
 |
ALKERMES PLC | -1.6% |
|
ARCELLX, INC. | -1.4% |